Veterinary oncology receives global boostJune 1, 2021Enhancing the global standard of treatment for pets diagnosed with cancer is the goal of WSAVA’s newest committee.
SPONSORED CONTENTHelping manage the hidden signs of stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More
Early cancer detection can save pets' livesMay 26, 2021Educating owners on the role regular wellness checks can play in early cancer detection and treatment is the goal of a newly launched campaign.
Studies supporting canine cancer prevention, treatment get fundingMay 10, 2021The AKC Canine Health Foundation has announced grants totaling more than $850,000 for 11 projects focused on canine oncology.
Cancer research campaign to match donationsMay 10, 2021Merck, Petco Love, and Blue Buffalo will match contributions up to $100,000 for Morris Animal Foundation’s “Stop Cancer Furever” campaign.
Oral cancer: Not just for older petsApril 19, 2021We generally think of oral cancer as a condition that affects middle-aged and older pets, but there are some types of neoplasia that are more common in young pets.
Cancer misdiagnosis may be common in English bulldogsFebruary 11, 2021Research out of CSU suggests a high B-cell count does not necessarily indicate cancer in English bulldogs, Morris Animal Foundation reports.
Cancer funding improves pets' access to careFebruary 1, 2021Pets battling cancer in the Lone Star State will have improved access to veterinary treatment and care, thanks to a new round of funding.
Feline oral cancer, DCM therapies to be exploredJanuary 5, 2021Dilated cardiomyopathy (DCM), oral squamous cell carcinoma (OSCC), and canine distemper virus (CDV) may soon see new treatments, thanks to Morris Animal Foundation.
Blood test streamlines canine cancer detectionDecember 9, 2020Texas A&M has introduced a simplified oncology test that allows for early diagnosis in dogs.
MCT intratumoral injectable gets green lightNovember 19, 2020Dogs afflicted with non-metastatic mast cell tumors (MCTs) can now benefit from a new and novel treatment method.
